Divis Laboratories Ltd | DIVI - Current Assets



Divis Laboratories Ltd reported 100.81B in Current Assets for its fiscal quarter ending in March of 2025.


Current Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Aurobindo Pharma INR 271.62B 9.37B Mar/2025
Avita Medical AUD 57M 15.96M Dec/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Divis Laboratories Ltd 100.81B 7.4B Mar/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
Lupin INR 167.99B 17.78B Mar/2025
Moderna USD 6.17B 595M Jun/2025
Organon & Co USD 4.62B 247M Jun/2025
Revvity USD 2.24B 81.76M Jun/2025
Tectonic Therapeutic USD 290.85M 143.99M Jun/2025
Tilray USD 707.34M 18.54M Nov/2024
Viatris USD 9.77B 152.2M Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025